While brand-based and generic TLDs are fascinating in terms of their potential to shake-up domain name giants and revolutionize online branding, only a handful of them will possess staying power.
With billions of dollars at stake and neither company certain how it might fare in court, a brand-name manufacturer might prefer to pay its potential competitor substantial compensation to delay its generic drug and the generic maker might welcome a hefty payoff rather than face the uncertainties of litigation and marketing.